HomeMarkets Markets Moderna’s Personalized mRNA Cancer Vaccine Shows Promising Results in Early Trial By news December 21, 2022 0 122 FacebookTwitterPinterestWhatsApp Moderna’s personalized cancer vaccine was shown to reduce the risk of recurrence in patients with stage 3 or 4 melanoma in a phase 2b clinical trial. …This post was originally published on this site Share FacebookTwitterPinterestWhatsApp Subscribe Login Notify of new follow-up comments new replies to my comments Please login to comment 0 Comments Inline Feedbacks View all comments Stay Connected157,317FansLike396,312FollowersFollow2,290SubscribersSubscribe Latest Articles Markets Big Tech keeps spending billions on AI. There’s no end in sight. Markets Cybersecurity researchers spotlight a new ransomware threat – be careful where you upload files Markets Why is China risking US sanctions by arming Russia? Survival Markets Trump trial reveals details about how the former president thinks about, and exploits, the media Top Trades Top Trade Alert – April 26, 2024 – Intel (INTC) Load more